Jennifer Van Eyk has been named the inaugural director of Cedars-Sinai's Advanced Clinical Biosystems Research Institute, Cedars-Sinai said this week. She also will lead basic research at the Cedars-Sinai Barbara Streisand Women's Heart Center.
Van Eyk joins Cedars-Sinai from Johns Hopkins University School of Medicine. A proteomics investigator, she is known for developing lab tests to determine the presence of proteins in blood that could indicate whether a patient has experienced a heart attack or has heart disease. She will remain director of the National Heart Lung and Blood Institute Proteomic Innovation Center on Heart Failure, a contract NHLBI awarded to her group at Johns Hopkins.
Agilent said this week that it has appointed Biogen Idec CEO George Scangos to its board of directors, effective September.
Prior to Biogen, Scangos served as president and CEO of Exelixis, a drug discovery and development company. He was previously president of Bayer Biotechnology.